Technology
Why Gixam™
Because Screening for Colorectal Cancer Needs to be Easy and User Friendly
Ease of Use Brings Better Compliance
Gixam™ is aimed to be put in the hands of physicians, from family doctors to GI practitioners, negating the need to send patients to conduct home tests, saving medical labs valuable time, resources and money. Gixam™, as a user friendly, non-invasive device, is the perfect solution to dramatically increase compliance percentages and lead the way in the efforts to reduce worldwide Colorectal Cancer instances.
Immediate Results Save Valuable Resources
Using Gixam™ means that valuable and costly lab time is mitigated. Furthermore, with instantaneous results, doctors can decide on a medical path, saving both the patient and the healthcare industry time and resources.
Early Detection Equates to Better Accuracy and Saves Lives
Early detection saves lives. Gixam™ is set to detect colorectal adenomas as they start their growth development, referred to as stage 0, while the FOBT/FIT test, commonly used today, detects the presence of adenomas at a later stage. By taking the hassle out of the test, Gixam™ is poised to become the leading alternative for pre-screening tests.
Gixam™ – Our Breakthrough Solution
The search for biological changes that accurately detect early signs of GI disorders, led Jubaan to develop a new type of screening test combining Image Analysis, Deep Learning, Artificial Intelligence and Microbiome Mapping
Seeing What is Impossible to Detect
The human eye can only detect and process three primary colors: Red, Green and Blue. The naked eye is unable to process the much wider color spectrum within the complex tongue structure, and this is where Image Analysis together with optic strength come into play. Using Image Analysis algorithms, Jubaan not only focuses on areas of the color spectrum visible to the human eye, but goes deeper using Spectral Imagery algorithms searching for "tell-tale" signs of disease within the color spectrum that are not visible to the human eye.
Changing the Way Colorectal Adenomas are Detected
By utilizing cutting-edge and advanced technologies, Jubaan is set to become a game-changer for early detection of GI disorders, saving the healthcare industry valuable resources and most importantly saving lives by providing better and expedient patient outcomes.
Deep Learning Brings Intuitive and Accurate Predictions
The FOBT/FIT tests are standard pre-screening tests in many countries. However, they lack accuracy and more importantly extremely low patient compliance due to the nature and requirements required to complete both tests. Gixam™ solves both problems with an intuitive, hassle-free and accurate prediction engine.